INSM posts wider-than-expected Q4 loss. It reiterates its 2025 sales outlook for Arikayce in the range of $405-$425 million.
About the Cystic Fibrosis Trust Cystic Fibrosis Trust is the only UK-wide charity dedicated to uniting for a life unlimited for everyone affected by cystic fibrosis. The Trust funds cutting edge ...
Attila is a Staff Writer for CNET, covering software, apps and services with a focus on virtual private networks. He is an advocate for digital privacy and has been quoted in online publications ...
Tuberous sclerosis complex manifests predominantly as a neurocutaneous disorder Lung involvement was considered rare. Lymphangioleiomyomatosis which occurs mainly in women of childbearing age is ...
You just throw what you can at it.” As a result, he said his family just “dealt with it as best we could,” while Mac underwent multiple treatments. “He had surgeries and radiation and 25 ...
Gov. DeWine: Big Mac Bridge to fully reopen Sunday evening, a month ahead of schedule Their relationship is still going strong. The Trump administration evicted former Coast Guard Commandant Linda ...
Insmed's promising drug pipeline includes Brensocatib and Arikayce. See why INSM stock is a strong pick with multi-billion dollar market potential.
Treatment also depends on your general health and where the melanoma is on your body. Surgery is the main treatment for melanoma skin cancer. Unfortunately, if the cancer has spread to places such as ...
Can be done at home. Cons: Costly. Must be used indefinitely. Evidence of efficacy is mixed. Cost: For at-home treatment, a one-time cost of $500 to $3,000 for the apparatus. What it is: A ...
There is a commercial access agreement for pembrolizumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact [email protected] ...
Lung biopsy is a relatively frequently performed procedure with considerable benefit for patient management but it may, on rare occasions, result in the death of the patient. It is a multidisciplinary ...